Dupixent 300 MG/2 ML pen 2ML

Ended Awarded Last action

Contract number
SPE2DR26F51DR
Awardee
Awarding agency
Obligated
$25,492

Award facts

Contract value 100% obligated
$25,491.61 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $25,491.61 delivery order to AmerisourceBergen Drug Corp on May 21, 2026, for Dupixent 300 mg/2 ml pen injectables, with ultimate completion on May 22, 2026.

The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX series), which supplies pharmaceutical products and medical devices to Defense Health Agency facilities and military treatment facilities worldwide. Place of performance is Conshohocken, PA. This is a firm fixed-price pharmaceutical delivery order, one of hundreds of thousands of transactional calls AmerisourceBergen executes annually against its standing DLA pharmaceutical supply agreements.

Quick answers

Who was awarded contract SPE2DR26F51DR?

SPE2DR26F51DR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 21, 2026.

How much is contract SPE2DR26F51DR worth?

The government has obligated $25,492 on SPE2DR26F51DR.

Is contract SPE2DR26F51DR an order under another contract?

Yes. SPE2DR26F51DR is a delivery order under SPE2DR25D2101, an indefinite delivery contract.

Was contract SPE2DR26F51DR competed?

The extent of competition for SPE2DR26F51DR was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award